AL
ALTUV.PA BIO UV Group
- Market cap
- EUR 10.7M
- P/E
- 78.8x
- P/B
- 0.26x
- ROE
- 6.7%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is ALTUV.PA undervalued?
Graham numberALTUV.PA trades 4.7% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BIO UV Group fundamental analysis
6 of 11 checks passedROE 1/2
ROE in an average range (7.67%) suggests satisfactory profitability and decent utilization of shareholders' equity.
ROA 1/2
The stock's ROA (7.02%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.
PBV 2/2
The stock's low PBV ratio (0.8x) suggests it's undervalued, making it an attractive opportunity for investors.
DER 0/2
The stock is burdened with a heavy load of debt (105%), making it financially unstable and potentially risky for investors.
Revenue Growth 0/2
Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.
Net Profit Growth 0/2
This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.
Assets Growth 0/2
Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.
Graham Number 1/1
The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.
Dividend Growth 1/2
The company's dividend growth has shown a positive trajectory over the past three years, consistently increasing year after year, indicating a favorable trend for potential investors.
Dividend 0/2
No dividends from the company in the past three years raises doubts about its profitability for shareholders.
Buffet Intrinsic Value 1/1
The company's stock seems undervalued (15) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
BIO UV Group stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BIO UV Group
BIO-UV Group S.A. designs, manufactures, and markets water treatment and disinfectant systems using ultraviolet, salt electrolysis, ozone, and advanced oxidation for individuals and professionals in France, Europe, Asia, the Middle East, the United States, and internationally. The company offers disinfection equipment and systems under the triogen, AKERON, 1001 Electrodes, and BIOSEA brands; spare parts; and commissioning services. It also provides maintenance services compr…
Full company profileBIO UV Group financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BIO UV Group annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 9.62M | 10.2M | 12.4M | 20.0M | 32.2M | 33.5M | 51.3M | 43.1M | 39.6M | 35.9M | 80.4M |
| Gross Profit | 3.55M | 4.46M | 4.63M | 6.43M | 1.78M | 1.84M | 4.71M | 25.6M | 24.1M | 2.00M | 6.51M |
| Operating Income | -343K | 406K | 14.8K | -307K | 1.40M | 998K | 4.13M | 2.30M | 2.13M | 1.18M | 4.17M |
| EBITDA | 960K | 1.07M | 862K | 1.21M | 3.23M | 3.35M | 6.38M | 4.43M | 4.18M | 1.60M | 8.94M |
| Net Income | 1.28M | -91.3K | 46.3K | -448K | 584K | 689K | 2.42M | 125K | 31.4K | 836K | 2.77M |
| EPS | 0.16 | -0.01 | 0.01 | -0.06 | 0.07 | 0.07 | 0.23 | 0.01 | 0.00 | 0.06 | 0.20 |
| Balance Sheet | |||||||||||
| Total Assets | 17.2M | 17.9M | 28.4M | 36.3M | 51.9M | 81.1M | 74.1M | 71.4M | 66.1M | 69.2M | 72.0M |
| Total Liabilities | 11.0M | 11.9M | 11.7M | 20.2M | 21.7M | 50.4M | 41.7M | 39.2M | 33.4M | 28.7M | 30.8M |
| Shareholders' Equity | 6.09M | 6.00M | 16.8M | 16.0M | 30.2M | 30.5M | 32.2M | 32.2M | 32.7M | 40.5M | 41.1M |
| Cash & Short-term Investments | 2.17M | 1.01M | 5.92M | 2.20M | 12.6M | 10.6M | 1.98M | 2.73M | 3.87M | 10.2M | 7.75M |
| Total Debt | 8.37M | 10.3M | 6.65M | 13.5M | 13.7M | 30.7M | 29.2M | 28.3M | 24.0M | 20.2M | 18.4M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -677K | 1.99M | -1.89M | -585K | -122K | 3.30M | 2.70M | 6.24M | 6.90M | 4.63M | 2.00M |
| Capital Expenditure | 806K | 3.22M | 1.97M | 1.91M | 3.20M | 2.73M | 2.22M | 1.96M | 1.90M | 1.64M | 2.80M |
| Free Cash Flow | -1.48M | -1.23M | -3.86M | -2.49M | -3.32M | 572K | 476K | 4.28M | 5.00M | 3.00M | -800K |
| Ratios | |||||||||||
| ROE | 21.0% | -1.5% | 0.3% | -2.8% | 1.9% | 2.3% | 7.5% | 0.4% | 0.1% | 2.1% | 6.7% |
| ROA | 7.4% | -0.5% | 0.2% | -1.2% | 1.1% | 0.8% | 3.3% | 0.2% | 0.0% | 1.2% | 3.8% |
| Net Profit Margin | 13.3% | -0.9% | 0.4% | -2.2% | 1.8% | 2.1% | 4.7% | 0.3% | 0.1% | 2.3% | 3.4% |
| Debt to Equity | 1.37x | 1.72x | 0.40x | 0.85x | 0.45x | 1.01x | 0.90x | 0.88x | 0.73x | 0.50x | 0.45x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
BIO UV Group dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Sep 27, 2023
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | EUR 607K | 0.06 | 486.1% |
| 2022 | EUR 505K | 0.05 | 20.9% |
| 2021 | EUR 505K | 0.05 | 73.3% |
| 2020 | EUR 14.3K | 0.00 | 2.5% |
| 2019 | EUR 505K | 0.06 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 870:869 on Jan 29, 2025.
Who owns BIO UV Group
- Insiders 1.30%
- Institutions 5.26%
- Public & others 93.45%
- Shares outstanding 13.6M
- Free float 13.4M
BIO UV Group company profile
- Company name
- BIO UV Group
- Ticker
- ALTUV.PA
- ISIN
- FR0013345493
- Exchange
- Euronext Paris
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Employees
- 143
- Fiscal year end
- December
- Address
- 850 avenue Louis Médard, Lunel, France, 34400
- Phone
- 33 4 99 13 39 11
- Website
- bio-uv.com
About BIO UV Group
BIO-UV Group S.A. designs, manufactures, and markets water treatment and disinfectant systems using ultraviolet, salt electrolysis, ozone, and advanced oxidation for individuals and professionals in France, Europe, Asia, the Middle East, the United States, and internationally. The company offers disinfection equipment and systems under the triogen, AKERON, 1001 Electrodes, and BIOSEA brands; spare parts; and commissioning services. It also provides maintenance services comprising inspection and diagnosis; cleaning and replacement of parts; calibration and adjustments; updates and upgrades; and training and technical support services. The company's products are used in residential and commercial pools, aquariums, aquaculture, industrial water, municipal and domestic water, wastewater and reuse, and ballast water applications. It exports its products. BIO-UV Group S.A. was founded in 2000 and is headquartered in Lunel, France.
BIO UV Group management
5- Mr. Laurent-Emmanuel MigeonChairman, CEO and Sales & Marketing Director
- Mr. Pierric BryonDirector of Finance & Support Functions
- Mr. Gilles WallezDirector of Operations
- Mr. Xavier BayleR&D Director and Director
- Mr. Jean-Philippe Picard de MullerDirector of the Services Division & Deputy CEO